Literature DB >> 12680797

Extracranial stereotactic radiation delivery: expansion of technology beyond the brain.

Robert Timmerman1, Lech Papiez, Mohan Suntharalingam.   

Abstract

The development of improved immobilization systems, and a greater understanding of the radiobiologic considerations associated with stereotactic radiotherapy has recently led to the clinical implementation of this technology to extracranial sites. The shared principles of targeting and treatment delivery has led to a greater understanding of the potential role this therapy may have in the management of extracranial disease. This article will review, the radiobiologic considerations and the basic principles of physics and dosimetry that help govern the utilization of extracranial stereotactic radiotherapy. In addition, this article will summarize the data that exists in the literature to date, that has documented the rationale, and efficacy of this novel therapeutic approach.

Mesh:

Year:  2003        PMID: 12680797     DOI: 10.1177/153303460300200212

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  10 in total

1.  A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question?

Authors:  Carsten Nieder; Nicolaus H Andratschke; Matthias Guckenberger
Journal:  Ann Transl Med       Date:  2015-07

Review 2.  Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Authors:  Drew Moghanaki; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2016-04

Review 3.  Stereotactic radiotherapy in the liver hilum. Basis for future studies.

Authors:  C Zamboglou; M-B Messmer; G Becker; F Momm
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

4.  Outcome After Resection of Craniopharyngiomas and the Important Role of Stereotactic Radiosurgery in Their Management.

Authors:  Tomokatsu Hori; Kosaku Amano; Takakazu Kawamata; Motohiro Hayashi; Genichiro Ohhashi; Shinichiro Miyazaki; Masami Ono; Nobuhiro Miki
Journal:  Acta Neurochir Suppl       Date:  2021

5.  Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis.

Authors:  K A Paschos; N Bird
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

6.  Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.

Authors:  Stephanie E Combs; Daniel Habermehl; Tom Ganten; Jan Schmidt; Lutz Edler; Iris Burkholder; Oliver Jäkel; Thomas Haberer; Jürgen Debus
Journal:  BMC Cancer       Date:  2011-02-12       Impact factor: 4.430

7.  Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study.

Authors:  Antje Ernst-Stecken; Ulrike Lambrecht; Reinhold Mueller; Rolf Sauer; Gerhard Grabenbauer
Journal:  Strahlenther Onkol       Date:  2006-12       Impact factor: 3.621

8.  Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy.

Authors:  William T Kearns; James J Urbanic; Carnell J Hampton; Kevin P McMullen; A William Blackstock; Volker W Stieber; William H Hinson
Journal:  J Appl Clin Med Phys       Date:  2008-06-23       Impact factor: 2.102

9.  Characterization and evaluation of 2.5 MV electronic portal imaging for accurate localization of intra- and extracranial stereotactic radiosurgery.

Authors:  Kwang Hyun Song; Karen Chin Snyder; Jinkoo Kim; Haisen Li; Wen Ning; Robert Rusnac; Paul Jackson; James Gordon; Salim M Siddiqui; Indrin J Chetty
Journal:  J Appl Clin Med Phys       Date:  2016-07-08       Impact factor: 2.102

Review 10.  Immunomodulatory Effects of Radiotherapy.

Authors:  Sharda Kumari; Shibani Mukherjee; Debapriya Sinha; Salim Abdisalaam; Sunil Krishnan; Aroumougame Asaithamby
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.